
Children with zzso have low bone zzso Pathways for zzso bone disease were investigated in children with cancer by zzso assessing lifestyle, clinical, and zzso zzso of bone zzso zzso children who were receiving cancer therapy for 61 weeks and 39 controls were zzso Data on lifestyle factors, zzso and hormonal zzso zzso X-ray zzso bone mass zzso body zzso and bone age were zzso Compared with controls, patients had higher weight zzso and fat mass, a zzso delay in bone age, and lower zzso zzso They also had higher zzso hormone levels and lower bone zzso markers and bone zzso Age, zzso lean mass, fat mass, and bone maturation correlated positively with several bone mass zzso so did serum zzso testosterone, and markers of bone zzso zzso zzso zzso zzso and zzso therapy zzso correlated with bone mass at the spine and hip (R zzso zzso to zzso p zzso zzso In the adjusted zzso bone zzso serum zzso level, zzso and zzso therapy were significant zzso of zzso spine and total body zzso bone maturation accounting for the largest proportion in zzso zzso zzso delay in bone maturation and suppression of bone modeling are major zzso pathways predicting bone mass in children with zzso 

